共 50 条
- [41] New evidence for a role of MICA in the pathogenesis of systemic lupus erythematosus: comment on the article by Yoshida et al ARTHRITIS AND RHEUMATISM, 2012, 64 (04): : 1294 - 1295
- [43] The role of nuclear medicine in the evaluation of neuropsychiatric systemic lupus erythematosus: comment on the article by Sibbitt et al ARTHRITIS AND RHEUMATISM, 2000, 43 (08): : 1903 - 1904
- [45] Low bone density and vertebral fractures in systemic lupus erythematosus: comment on the article by Bultink et al ARTHRITIS AND RHEUMATISM, 2006, 54 (01): : 378 - 379
- [47] Exacerbation of systemic lupus erythematosus after hepatitis B vaccination: comment on the article by Battafarano et al and the letter by Senecal et al ARTHRITIS AND RHEUMATISM, 2000, 43 (02): : 468 - 468
- [48] Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al ARTHRITIS AND RHEUMATISM, 2005, 52 (03): : 988 - 989
- [49] Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia Arthritis Research & Therapy, 24
- [50] Potential effects of cyclosporin A on coronary vasomotor function in young patients with systemic lupus erythematosus: comment on the article by Hirata et al ARTHRITIS AND RHEUMATISM, 2008, 58 (01): : 330 - 331